Literature DB >> 8116514

Primary brain tumors: review of etiology, diagnosis and treatment.

H B Newton1.   

Abstract

The activation of oncogenes and the inactivation of tumor suppressor genes within neoplastic cells lead to transformation and loss of growth control. The key clinical feature that should arouse suspicion of a primary brain tumor and lead to a prompt evaluation is the progressive nature of the signs and symptoms, which include headaches, nausea and emesis, double vision, change in personality or cognition, speech difficulty, seizures and weakness. Neuroimaging with contrast-enhanced computed tomography or magnetic resonance imaging is the best method of confirming the presence of a primary brain tumor. Initial treatment in most patients is biopsy or surgical resection. For malignant and selected benign primary brain tumors, further treatment is necessary and may include radiation therapy, chemotherapy or experimental protocols.

Entities:  

Mesh:

Year:  1994        PMID: 8116514

Source DB:  PubMed          Journal:  Am Fam Physician        ISSN: 0002-838X            Impact factor:   3.292


  18 in total

Review 1.  Treatment of brain metastases in renal cell carcinoma: radiotherapy, radiosurgery, or surgery?

Authors:  Alexander Muacevic; Michael Siebels; Jörg-Christian Tonn; Berndt Wowra
Journal:  World J Urol       Date:  2005-03-25       Impact factor: 4.226

2.  An inverse problem formulation for parameter estimation of a reaction-diffusion model of low grade gliomas.

Authors:  Amir Gholami; Andreas Mang; George Biros
Journal:  J Math Biol       Date:  2015-05-12       Impact factor: 2.259

3.  Does streaming affect the cerebral distribution of infraophthalmic intracarotid chemotherapy?

Authors:  Ronit Agid; Rina Rubinstein; Tali Siegal; Hava Lester; Felix Bokstein; Roland Chisin; John M Gomori
Journal:  AJNR Am J Neuroradiol       Date:  2002 Nov-Dec       Impact factor: 3.825

4.  Inhibitors of Glioma Growth that Reveal the Tumour to the Immune System.

Authors:  Manuel Nieto-Sampedro; Beatriz Valle-Argos; Diego Gómez-Nicola; Alfonso Fernández-Mayoralas; Manuel Nieto-Díaz
Journal:  Clin Med Insights Oncol       Date:  2011-09-21

Review 5.  Notch signaling in glioblastoma: a developmental drug target?

Authors:  Maria Maddalena Lino; Adrian Merlo; Jean-Louis Boulay
Journal:  BMC Med       Date:  2010-11-15       Impact factor: 8.775

6.  Prevalence and rupture rate of cerebral aneurysms discovered during intra-arterial chemotherapy of brain tumors.

Authors:  E C Bourekas; H B Newton; G M Figg; H W Slone
Journal:  AJNR Am J Neuroradiol       Date:  2006-02       Impact factor: 3.825

7.  Differential Apaf-1 levels allow cytochrome c to induce apoptosis in brain tumors but not in normal neural tissues.

Authors:  Carrie E Johnson; Yolanda Y Huang; Amanda B Parrish; Michelle I Smith; Allyson E Vaughn; Qian Zhang; Kevin M Wright; Terry Van Dyke; Robert J Wechsler-Reya; Sally Kornbluth; Mohanish Deshmukh
Journal:  Proc Natl Acad Sci U S A       Date:  2007-12-18       Impact factor: 11.205

8.  Retrospective analysis of the efficacy and tolerability of levetiracetam in brain tumor patients.

Authors:  Herbert B Newton; Samuel A Goldlust; Dennis Pearl
Journal:  J Neurooncol       Date:  2006-03-16       Impact factor: 4.130

9.  Iron oxide nanoparticles as a drug delivery vehicle for MRI monitored magnetic targeting of brain tumors.

Authors:  Beata Chertok; Bradford A Moffat; Allan E David; Faquan Yu; Christian Bergemann; Brian D Ross; Victor C Yang
Journal:  Biomaterials       Date:  2007-10-26       Impact factor: 12.479

10.  GSK3beta regulates differentiation and growth arrest in glioblastoma.

Authors:  Serdar Korur; Roland M Huber; Balasubramanian Sivasankaran; Michael Petrich; Pier Morin; Brian A Hemmings; Adrian Merlo; Maria Maddalena Lino
Journal:  PLoS One       Date:  2009-10-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.